Trademark: 79243566
Word
CANNABIXIR
Status
Registered
Status Code
700
Status Date
Tuesday, May 5, 2020
Serial Number
79243566
Registration Number
6044448
Registration Date
Tuesday, May 5, 2020
Mark Type
4000
Filing Date
Thursday, June 14, 2018
Published for Opposition
Tuesday, February 18, 2020

Trademark Owner History
Oxygen Handel GmbH - Original Registrant

Classifications
3 Bleaching preparations for laundry use; non-medicated soaps; essential oils; non-medicated cosmetics; non-medicated hair lotions; non-medicated dentifrices; non-medicated toiletry preparations; non-medicated make-up; non-medicated soaps and gels; non-medicated bath preparations; non-medicated deodorants and antiperspirants; non-medicated skin, eye and nail care preparations; non-medicated hair preparations and treatments; essential oils and aromatic extracts; household cleaning preparations; air fragrancing preparations; household fragrances; balms, other than for medical purposes for use on hair, skin, lips; cosmetics and cosmetic preparations; oils for cosmetic purposes; massage oils; mineral oils for cosmetic purposes; ointments for cosmetic use; non-medicated body mist; cosmetic shower preparations; cosmetic, namely, fluid creams; body and facial butters; body and facial oils; facial peel preparations for cosmetic use; cleaning masks for the face; hair and body wash; cosmetic preparations for bath and shower; cosmetic creams and lotions; topical herbal extracts for cosmetic purposes; make-up preparations; beauty balm creams; beauty milk; beauty care cosmetics; cosmetics in the form of creams; beauty serums; none of the aforementioned goods containing cannabinoids
5 Pharmaceuticals preparations for the treatment of pain, including chronic pain, neuropathic pain and fibromyalgia, mental diseases, including anxiety disorders, diseases of the nerves, depression, attention deficit/hyperactivity disorder, bipolar disorder and post-traumatic stress disorder, diseases of the central nervous system, including multiple sclerosis, spinal cord injury, epilepsy, Alzheimer's disease and autism, neuromuscular diseases, degenerative diseases, including glaucoma, cancer and insomnia as well as side effects, including nausea, vomiting, lack of appetite and weight loss; medical preparations for the treatment of pain, including chronic pain, neuropathic pain and fibromyalgia, mental diseases, including anxiety disorders, diseases of the nerves, depression, attention deficit/hyperactivity disorder, bipolar disorder and post-traumatic stress disorder, diseases of the central nervous system, including multiple sclerosis, spinal cord injury, epilepsy, Alzheimer's disease and autism, neuromuscular diseases, degenerative diseases, including glaucoma, cancer and insomnia as well as side effects, including nausea, vomiting, lack of appetite and weight loss; veterinary preparations for rodents, cats, dogs, guinea pigs, rabbits, for treatment of pain, including chronic pain, neuropathic pain and fibromyalgia, diseases of the nerves, diseases of the central nervous system, including multiple sclerosis, spinal cord injury, neuromuscular diseases, degenerative diseases, including glaucoma, cancer as well as side effects, including nausea, vomiting, lack of appetite and weight loss; sanitary preparations for medical purposes; dietetic food adapted for medical or veterinary use; dietary supplements for humans and animals; cachets for pharmaceutical purposes; medicated dentifrices; disinfectants and antiseptics; air deodorizers and air purifying preparations; medicated and sanitizing soaps and detergents for personal use; diagnostic preparations for medical use and veterinary use; natural remedies for pain, including chronic pain, neuropathic pain and fibromyalgia, mental diseases, including anxiety disorders, diseases of the nerves, depression, attention deficit/hyperactivity disorder, bipolar disorder and post-traumatic stress disorder, diseases of the central nervous system, including multiple sclerosis, spinal cord injury, epilepsy, Alzheimer's disease and autism, neuromuscular diseases, degenerative diseases, including glaucoma, cancer and insomnia as well as side effects, including nausea, vomiting, lack of appetite and weight loss; medical plasters; analgesics; appetite stimulant preparations; medicines for human purposes used for the treatment of pain, including chronic pain, neuropathic pain and fibromyalgia, mental diseases, including anxiety disorders, diseases of the nerves, depression, attention deficit/hyperactivity disorder, bipolar disorder and post-traumatic stress disorder, diseases of the central nervous system, including multiple sclerosis, spinal cord injury, epilepsy, Alzheimer's disease and autism, neuromuscular diseases, degenerative diseases, including glaucoma, cancer and insomnia as well as side effects, including nausea, vomiting, lack of appetite and weight loss; autonomic drugs for medical purposes; pharmaceutical preparations acting on the central nervous system; balms for medical purposes; balms for pharmaceutical purposes; sedatives; deodorants, other than for human beings or for animals; deodorizing room sprays; dragees for medicinal purposes; drugs for medical purposes; pharmaceutical preparations, namely, elixirs for the treatment of pain, including chronic pain, neuropathic pain and fibromyalgia, mental diseases, including anxiety disorders, diseases of the nerves, depression, attention deficit/hyperactivity disorder, bipolar disorder and post-traumatic stress disorder, diseases of the central nervous system, including multiple sclerosis, spinal cord injury, epilepsy, Alzheimer's disease and autism, neuromuscular diseases, degenerative diseases, including glaucoma, cancer and insomnia as well as side effects, including nausea, vomiting, lack of appetite and weight loss; anti-inflammatories; preparations for making medicated beverages; extracts of medicinal plants; ground hempseed fiber for use as a dietary supplement; medicated moisturizing body lotion; medicated moisturizing creams; liquid herbal supplements; nutraceuticals for use as a dietary supplement; topical gels for medical and therapeutic use, namely, pain, including chronic pain, neuropathic pain and fibromyalgia, mental diseases, including anxiety disorders, diseases of the nerves, depression, attention deficit/hyperactivity disorder, bipolar disorder and post-traumatic stress disorder, diseases of the central nervous system, including multiple sclerosis, spinal cord injury, epilepsy, Alzheimer's disease and autism, neuromuscular diseases, degenerative diseases, including glaucoma, cancer and insomnia as well as side effects, including nausea, vomiting, lack of appetite and weight loss; medicinal drinks; skin care preparations for medical use; medicinal herbs in dried or preserved form; extracts of medicinal herbs; homeopathic pharmaceuticals for use in treatment of pain, including chronic pain, neuropathic pain and fibromyalgia, mental diseases, including anxiety disorders, diseases of the nerves, depression, attention deficit/hyperactivity disorder, bipolar disorder and post-traumatic stress disorder, diseases of the central nervous system, including multiple sclerosis, spinal cord injury, epilepsy, Alzheimer's disease and autism, neuromuscular diseases, degenerative diseases, including glaucoma, cancer and insomnia as well as side effects, including nausea, vomiting, lack of appetite and weight loss; inhalants for medicinal purposes; capsules for medicines; chewing gum for medical purposes; germicides; medicinal herbs; smoking herbs for medical purposes; herbal extracts for medical purposes; herbal extracts for medicinal purposes; herbal beverages for medicinal use; herbal preparations for medical use; herbal teas for medicinal purposes; hempseed for pharmaceutical purposes; hempseed meal for pharmaceutical purposes; liniments; air deodorizing preparations; hemp milk for pharmaceutical purposes; hemp oil for pharmaceutical purposes; medicated shampoos; medicinal sprays; medicinal tea; medicated food supplements for pain, including chronic pain, neuropathic pain and fibromyalgia, mental diseases, including anxiety disorders, diseases of the nerves, depression, attention deficit/hyperactivity disorder, bipolar disorder and post-traumatic stress disorder, diseases of the central nervous system, including multiple sclerosis, spinal cord injury, epilepsy, Alzheimer's disease and autism, neuromuscular diseases, degenerative diseases, including glaucoma, cancer and insomnia as well as side effects, including nausea, vomiting, lack of appetite and weight loss; hempseed dietary supplements for pain, including chronic pain, neuropathic pain and fibromyalgia, mental diseases, including anxiety disorders, diseases of the nerves, depression, attention deficit/hyperactivity disorder, bipolar disorder and post-traumatic stress disorder, diseases of the central nervous system, including multiple sclerosis, spinal cord injury, epilepsy, Alzheimer's disease and autism, neuromuscular diseases, degenerative diseases, including glaucoma, cancer and insomnia as well as side effects, including nausea, vomiting, lack of appetite and weight loss; hempseed oil dietary supplements for pain, including chronic pain, neuropathic pain and fibromyalgia, mental diseases, including anxiety disorders, diseases of the nerves, depression, attention deficit/hyperactivity disorder, bipolar disorder and post-traumatic stress disorder, diseases of the central nervous system, including multiple sclerosis, spinal cord injury, epilepsy, Alzheimer's disease and autism, neuromuscular diseases, degenerative diseases, including glaucoma, cancer and insomnia as well as side effects, including nausea, vomiting, lack of appetite and weight loss; prescription synthetic narcotics; nervines; nutraceutical preparations for therapeutic or medical purposes; medicinal oils; plant and herb extracts for medicinal use; pharmaceutical compositions for pain, including chronic pain, neuropathic pain and fibromyalgia, mental diseases, including anxiety disorders, diseases of the nerves, depression, attention deficit/hyperactivity disorder, bipolar disorder and post-traumatic stress disorder, diseases of the central nervous system, including multiple sclerosis, spinal cord injury, epilepsy, Alzheimer's disease and autism, neuromuscular diseases, degenerative diseases, including glaucoma, cancer and insomnia as well as side effects, including nausea, vomiting, lack of appetite and weight loss; reagents for medical use; syrups for pharmaceutical purposes; all of the aforementioned goods in particular for the treatment of pain, including chronic pain, neuropathic pain and fibromyalgia, mental diseases, including anxiety disorders, diseases of the nerves, depression, attention deficit/hyperactivity disorder, bipolar disorder and post-traumatic stress disorder, diseases of the central nervous system, including multiple sclerosis, spinal cord injury, epilepsy, Alzheimer's disease and autism, neuromuscular diseases, degenerative diseases, including glaucoma, cancer and insomnia as well as side effects, including nausea, vomiting, lack of appetite and weight loss; none of the aforementioned goods containing cannabinoids
CANNABIS ELIXIR

Trademark Events
Dec 24, 2021
New Representative At Ib Received
Oct 3, 2020
Final Decision Transaction Processed By Ib
Sep 11, 2020
Final Disposition Notice Sent To Ib
Sep 11, 2020
Final Disposition Processed
Aug 5, 2020
Final Disposition Notice Created, To Be Sent To Ib
May 5, 2020
Registered-Principal Register
Apr 3, 2020
Notification Of Possible Opposition - Processed By Ib
Mar 18, 2020
Notification Of Possible Opposition Sent To Ib
Mar 18, 2020
Notification Of Possible Opposition Created, To Be Sent To Ib
Feb 18, 2020
Official Gazette Publication Confirmation E-Mailed
Feb 18, 2020
Published For Opposition
Feb 14, 2020
Notification Processed By Ib
Jan 29, 2020
Notification Of Possible Opposition Sent To Ib
Jan 29, 2020
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Jan 29, 2020
Notification Of Notice Of Publication E-Mailed
Jan 16, 2020
Assigned To Lie
Jan 14, 2020
Approved For Pub - Principal Register
Dec 20, 2019
Teas/Email Correspondence Entered
Dec 20, 2019
Correspondence Received In Law Office
Dec 20, 2019
Teas Response To Office Action Received
Jul 27, 2019
Refusal Processed By Ib
Jun 20, 2019
Notification Of Non-Final Action E-Mailed
Jun 20, 2019
Non-Final Action E-Mailed
Jun 20, 2019
Non-Final Action Written
May 15, 2019
Teas/Email Correspondence Entered
May 15, 2019
Correspondence Received In Law Office
May 15, 2019
Teas Response To Office Action Received
May 10, 2019
Attorney/Dom.Rep.Revoked And/Or Appointed
May 10, 2019
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Dec 8, 2018
Refusal Processed By Ib
Nov 17, 2018
Non-Final Action Mailed - Refusal Sent To Ib
Nov 16, 2018
Refusal Processed By Mpu
Nov 15, 2018
Assigned To Examiner
Oct 27, 2018
Application Filing Receipt Mailed
Oct 26, 2018
Non-Final Action (Ib Refusal) Prepared For Review
Oct 25, 2018
Non-Final Action Written
Oct 23, 2018
Assigned To Examiner
Oct 23, 2018
New Application Office Supplied Data Entered In Tram
Oct 18, 2018
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24